2.5 mg retatrutide results Starting Dose: Full Dosing Guide and What to Expect Retatrutide for Weight Loss: TRIUMPH-1

Contrave is a combination of naltrexone and bupropion, which act on central pathways to inhibit appetite

[DOI] [PMC free article] [PubMed] [Google Scholar] Gong N, Xiao Q, Zhu B, Zhang CY, Wang YC, Fan H, Ma AN, Wang YX

GLP-1 medications have not been shown to increase TPO or thyroglobulin antibody levels

References A Montero et al., KFF health tracking poll May 2024: the publics use and views of GLP-1 drugs

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that activates both GIP and GLP-1 receptors, whereas traditional GLP-1 receptor agonists such as semaglutide and liraglutide target only the GLP-1 pathway